AIM: To study the mechanisms of the resistance to harringtonine (Har)
in the HL60 cells. METHODS: Growth inhibition, karyotype analysis, flo
w cytometry, Western blotting and polymerase chain reaction. RESULTS:
The Har-resistant HL60 cell line, named HR20, showed cross resistance
to homoharringtonine, doxorubicin, daunorubicin, vincristine, and colc
hicine. The growth doubling time and the cell numbers in G(1) phase we
re increased. The accumulation of cellular daunorubicin in the resista
nt cells was obviously reduced, but distinctly increased by tetrandrin
e and verapamil. The numbers of telocentromeric chromosome increased a
nd the chromosomal aberration more occured in the resistant cells. The
resistant cells overexpressed multidrug resistant mdr-1 gene and P-gl
ycoprotein 150 kDa. CONCLUSION: The Har-resistant HL60 cell strain bel
onged to a multidrug resistance strain, overexpressing mdr-1 gene and
P-glycoprotein.